CYCN Cyclerion Therapeutics, Inc.: Narxning prognoz qilingan daromadga nisbati

Cyclerion Therapeutics, Inc. (CYCN) brendining ramzi va logotipi

sGC stimulyatorlarining B2B litsenziyalashiga bog'liq kengayish xavflari tebranishlarni keltirib chiqarmoqda, buni GURU.Markets platformasidagi ushbu forward sotuvlar nisbati grafigi Cyclerion Therapeutics (CYCN) uchun aniq ko'rsatib turibdi. 7.50 qiymati eng so'nggi metrika ko'rsatkichini ifodalaydi. Aktivlarni monetizatsiya qilish va royalti to'lovlari barqarorlikni ta'minlashi mumkin bo'lsa-da, hozirgi vaqtda toraygan R&D pipeline va texnologik to'xtash davri aksiyalar narxining tez o'sish potentsialini cheklaydi.

CYCN (Cyclerion) Sotuvga nisbatan forvard narx tarixi 04.07.2022dan 09.09.2026gacha

Cyclerion Therapeutics, Inc. (CYCN) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- bozor narxi va tahlilchilarning maqsadli narxlari:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
Kompaniyaning dastlabki tahlili:CYCN (Cyclerion Therapeutics, Inc.)
cyclerion.com tovar namunasi

Ushbu koeffitsiyentning hisob-kitob modeli kelajakdagi daromadlar bo'yicha bozor kutganlarini o'lchaydi va potentsial kapitalizatsiya o'sishi bilan aktivlarning haddan tashqari yuqori baholanishi xavfi o'rtasidagi muvozanatni aks ettiradi. Geopolitik to'siqlar va Cyclerion Therapeutics (CYCN) terapiyasi uchun komponentlar yetkazib berishdagi uzilishlar prognozlar tebranishini kuchaytiradi; shuning uchun, kelajakdagi sotuvlarga nisbatan narx (forward price-to-sales) baholash tendentsiyasi operatsion noaniqlik sharoitida biznes modelining barqarorligi ko'rsatkichi bo'lib xizmat qiladi.

Muhim raqobatchilar

Forvard P/S multiplikatori BIIB (Biogen Idec)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Neurocrine Corp (NBIX)|RGC: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx AXSM (Axsome Therapeutics)|ACAD: Forvard P/S multiplikatori|Xenon Pharmaceuticals Inc. - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Viking Pharma|SUPN: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori CPRX|Forvard P/S multiplikatori denalitherapeutics.com (DNLI)|Forvard P/S multiplikatori HRMY (Harmony Biosciences Inc)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Biohaven (BHVN)|Amylyx Corp - Forvard P/S multiplikatori|TRVI - Forvard P/S multiplikatori|Praxis Precision Medicines Inc (PRAX) - Narxning prognoz qilingan daromadga nisbati|AVXL - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati CeriBell|Forvard P/S multiplikatori Prothena Corporation plc|Narxning prognoz qilingan daromadga nisbati Alector Therapeutics (ALEC)|Annexon Inc. - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati omeros.com OMER|neurogene.com (NGNE) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|acimmune.com - Forvard P/S multiplikatori|Voyager Therapeutics Inc (VYGR) - Forvard narx/daromad multiplikatori|Neumora Corp (NMRA) - Narxning prognoz qilingan daromadga nisbati|Scilex Holding Company, Inc. (SCLX) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori TVGN|Bozor kapitallashuvining kelajakdagi daromadga nisbati Alpha Cognition Inc. ACOG|Narxning prognoz qilingan daromadga nisbati cogrx.com (CGTX)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Inhibikase Therapeutics, Inc.|Forvard P/S multiplikatori SAVA (Cassava Sciences Inc)|Forvard P/S multiplikatori Assertio Holdings, Inc. ASRT|COYA - Narxning prognoz qilingan daromadga nisbati|Prognoz narxning daromadga nisbati Vistagen (VTGN)|OVID: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Acumen Pharmaceuticals Inc. (ABOS)|Forvard narx/daromad multiplikatori CRVO|Kapitalizatsiyaning prognoz qilingan daromadga nisbati ATHE (Alterity Therapeutics)|Narxning prognoz qilingan daromadga nisbati Clene Nanomedicine (CLNN)|PEPG (PepGen) - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Jupiter Neurosciences Inc JUNS|Sotuvga nisbatan forvard narx RLMD|ANVS - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Grace Therapeutics Inc|AIFF: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Klotho Neurosciences Inc (KLTO)|Narxning prognoz qilingan daromadga nisbati neurosense-tx.com|Bozor kapitallashuvining kelajakdagi daromadga nisbati Reviva Pharmaceuticals Holdings Inc. RVPH|Narxning prognoz qilingan daromadga nisbati MetaVia Inc. (MTVA)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati NeurAxis Inc|Forvard P/S multiplikatori HSDT (heliusmedical.com)|Sotuvga nisbatan forvard narx PASG|NEUP: Forvard narx/daromad multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Minerva Neurosciences Inc|Athira Pharma (ATHA) - Narxning prognoz qilingan daromadga nisbati|Addex Therapeutics, Ltd. - Sotuvga nisbatan forvard narx|ALZN (Alzamend Neuro) - Forvard P/S multiplikatori|PTIX (Protagenic Therapeutics) - Narxning kutilayotgan daromadga nisbati|Forvard P/S multiplikatori KTTA|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Cortigent|Forvard P/S multiplikatori ATXI (avenuetx.com)|BrainStorm Cell Therapeutics Inc. - Narxning prognoz qilingan daromadga nisbati|Cara Therapeutics Inc. - Forvard P/S multiplikatori|Chromocell Therapeutics (CHRO) - Forvard narx/daromad multiplikatori|ELYM: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Intra-Cellular Therapies Inc.|LBPH (Longboard Pharmaceuticals Inc) - Forvard P/S multiplikatori|Marinus - Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori NKGN|NRBO (NeuroBo Pharmaceuticals) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori SAGE (Sage Therapeutics Inc)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Synaptogenix Inc. (SNPX)|TRVN - Narxning prognoz qilingan daromadga nisbati|vigilneuro.com (VIGL) - Forvard narx/daromad multiplikatori|WENA: Forvard P/S multiplikatori|Cerevel Therapeutics, Inc. (CERE) - Forvard P/S multiplikatori